Protein that spurs spread of prostate cancer discovered

Washington, May 20 (ANI): Scientists have discovered that Stat5, a signaling protein previously found to be key to survival of prostate cancer, is also involved in metastasis.

The study, conducted by researchers from the Kimmel Cancer Center at Jefferson, demonstrates in both laboratory and animal models that nuclear Stat5 over-expression leads to a deadly spread of the cancer.

They add that their work with mice was unique in that it was the first time Stat5 was associated with prostate cancer metastasis processes in an animal model.

“Until now, we thought that Stat5 was involved in primarily promoting tumor growth, but this study indicates it could be one of the key players in pushing prostate cancer to spread,” said Marja Nevalainen, associate professor of Cancer Biology, Urology and Medical Oncology at Jefferson Medical College of Thomas Jefferson University.

“This seminal paper is sure to open up a new avenue of research, including investigation of therapies that could target Stat5 expression. Fresh approaches are needed since there are no effective therapies for prostate cancer that has metastasized,” Nevalainen added.

The study has been published in the online edition of Endocrine-Related Cancer. (ANI)

Gene mutation in liver cells to help with drug prescriptions

Washington, May 11 (ANI): A tiny gene mutation in human liver cells might help indicate proper dosage for half of all drugs, suggests a new American study.

The study has been published online in The Pharmacogenomics Journal.

Researchers at Ohio State University and colleagues have identified this mutation, and have shown that it alters the level of a protein in the liver responsible for processing between 45 per cent and 60 per cent of medications used to treat a wide range of conditions.

Each gene contains two alternative forms – called alleles – that are identical in most people.

However, in this case, the researchers found that the activity level, or expression, of one allele differs from its partner allele in a single gene.

That small difference is called a single nucleotide polymorphism, or SNP.

This SNP affects the gene””s protein-producing process, in turn lowering the level of an enzyme known as CYP3A4.

The faster a drug is processed, or metabolized, by this enzyme in the liver, the more quickly it is eliminated from that tissue and the body as a whole.

When this enzyme level is lowered by the presence of this SNP, people are likely to require smaller doses of medicines that the enzyme metabolizes.

But this also means that higher doses of these same drugs can be dangerous to people with the mutation if those levels become toxic.

The study further showed that people with the mutation who take a certain class of cholesterol-lowering drugs do indeed require lower doses of these medications to achieve the same effect that higher doses produce in people without the SNP.

The researchers suggest that this mutation could serve as a molecular biomarker to aid doctors in clinical practice, affecting dosing requirements, patients”” response to medications and toxicity levels of numerous drugs, especially anti-cancer medications.

Lead author Danxin Wang, a research scientist and adjunct assistant professor of pharmacology at Ohio State, said: “With some cancer drugs, there is a very narrow therapeutic index, meaning that if doctors give patients a slightly higher dose, it will cause toxicity. We believe this same biomarker could be used to predict that toxicity threshold in cancer patients.”

Wang noted that using this SNP as a biomarker could reduce the guesswork associated with prescribing drugs.

Wang said: “Right now, because there are no biomarkers available to predict CYP3A4 activity, trial and error determines whether cholesterol goes down with the prescribed dose.

“You never know who has what enzyme level, so you never really know what dose to give an individual if you don””t have a biomarker.” (ANI)

Insulin reduces obesity-related inflammation

Washington, May 11 (ANI): Scientists have found that one of the most common side effects of obesity – inflammation – can be fought by administering insulin.

As an added benefit, the team behind the work says, this also reduces a person”s risk of developing diabetes.

The remarkable finding was recently presented in a new thesis, written by experts at the Sahlgrenska Academy of the University of Gothenburg, in Sweden.

When you put on weight, your fat tissue grows and begins to produce a wealth of inflammatory molecules.

The increase in these inflammatory molecules leaves the fat tissue in a state of chronic inflammation.

This plays an important role in the development of insulin resistance, an early stage of type 2 diabetes, where the body is unable to regulate blood sugar levels using its own insulin.

“It”s still not entirely clear why obesity causes insulin resistance. Inflammation could be part of the reason why obesity leads to type 2 diabetes,” said Emelie Wallerstedt from the Institute of Medicine at the University of Gothenburg.

Research has shown that both obesity and insulin resistance are affected by inflammatory conditions in the body.

Previously it was believed that fat tissue served merely as a depository for fat, but now scientists know that it is also an important organ for the release of a wide range of different substances, including inflammatory molecules.

In the new study, the researchers managed to identify the properties of the inflammatory molecule IL-6.

“IL-6 impairs insulin signalling, but the insulin signalling itself can also inhibit and ”turn off” the IL-6 signal and inflammation. The protein PKCdelta also plays an important role in the regulation of the IL-6 signal, and we have shown that if we disable the function of this molecule, the inflammation decreases,” Wallerstedt said.

A greater understanding of these signalling mechanisms could make it possible in the future to develop medicines that can “turn off” the inflammation and so reduce the risk of insulin resistance and other obesity-related disorders. (ANI)

Protein jab mends broken bones

London, May 10 (ANI): Scientists have found a novel way to significantly speed up the healing of broken bones in mice, a feat which, if replicated in humans, could mean people with fractures would be free of their casts a lot sooner.

Jill Helms, Roel Nusse and team at Stanford University in California drilled small holes into the shin bones of mice, and injected them with Wnt proteins.

These proteins prompt bone stem cells to divide, reports New Scientist.

Three days later, bone growth was three times greater than in mice injected with a placebo, it was observed.

The approach could prove to be better than adding new stem cells, which can divide uncontrollably.

The research has appeared in the journal Science Translational Medicine. (ANI)

New protein involved in longevity identified

Washington, May 8 (ANI): The level of a single protein in the tiny roundworm C. elegans determines how long it lives, researchers in the Department of Biochemistry and Molecular Biology at Thomas Jefferson University have found.

Worms born without this protein, called arrestin, lived about one-third longer than normal, while worms that had triple the amount of arrestin lived one-third less.

The research also showed that arrestin interacts with several other proteins within cells to regulate longevity.

The human version of one of these proteins is PTEN, a well-known tumor suppressor. The study, to be published in the online edition of the Journal of Biological Chemistry, was chosen by the journal as the “Paper of the Week” – considered in the top one percent of published articles.

Because most proteins in worms have human counterparts, these findings may have relevance to human biology and the understanding of cancer development, said Jeffrey L. Benovic, Ph.D., professor and chair of the department.

“The links we have found in worms suggest the same kind of interactions occur in mammals although human biology is certainly more complicated. We have much work to do to sort out these pathways, but that is our goal,” said Dr. Benovic.

Researchers use the roundworm as a model because it offers a simple system to study the function of genes and proteins that are relevant to human biology. (ANI)

Acupuncture may aid spinal recovery

London, April 27 (ANI): Acupuncture – the procedure of inserting and manipulating filiform needles into various points on the body to relieve pain – may aid spinal injury recovery, says a new study.

A previous study showed that acupuncture can improve the sensory and motor functions of people with spinal cord injuries.

More recently, researchers at Kyung Hee University in Seoul, South Korea, tried to find out why, reports New Scientist.

Doo Choi and his colleagues damaged the spines of 75 rats. One third were treated with acupuncture.

After 35 days, the rats that received the needle treatment stood and walked better than those that did not.

What”s more, the acupuncture-treated rats had less nerve cell death and lower levels of the protein that causes inflammation.

The researchers hypothesize that the needles cause a stress response in the body that lessens inflammation.

The inflammation that occurs after spinal cord injuries causes nerve cell death and lessens the chance of recovery.

The study may have implications for spinal injury treatment in humans, though more research is needed.

The study”s results were published in the most recent edition of Neurobiology of Disease. (ANI)

Simplified test for early breast cancer detection on the anvil

Washington, Apr 17 (ANI): A library of synthetically produced antibodies that can detect and rapidly validate proteins secreted by breast cancer cells is being built by University of Arkansas researchers.

The researchers’ work will accelerate the process of developing a simple blood test for early detection of breast cancer.

“We want to implement a rapid screen that is sensitive – meaning highly accurate – non-invasive and inexpensive,” said Shannon Servoss, assistant professor of chemical engineering. “Such a test would be easy to use – as easy as a pregnancy test – and applicable to women of all ages, races and ethnicities. The ultimate goal, of course, is early detection of breast cancer.”

At the moment, researchers use specific protein binders called affinity reagents, which are molecules that interact with proteins, to recognize and validate proteins that indicate breast cancer. But this process is tedious and problematic because there are a limited number of affinity reagents available, and techniques to develop them are slow and expensive.

Servoss’s team seeks to overcome these obstacles by developing a collection of affitoids, which are synthetic, peptoid-based affinity reagents. A library of these affitoids, which are inexpensive and easy to make, will facilitate the development of techniques for protein validation.

The affitoids have other advantages. They can be designed to have desired properties, such as structural stability and specificity for a single protein. They also do not have to be limited to breast cancer detection. They could be designed to detect other complex diseases.

“This technique is superior to those currently available because affitoids specific for proteins secreted by breast cancer cells can be rapidly selected from a large collection, which isn’t too expensive to build,” Servoss said. “The selected affitoids will be used to determine a profile – a protein fingerprint – that indicates breast cancer. Of course, all of this is happening at the cell level, before the tumor is detectable.” (ANI)

Protein that speeds growth of damaged liver ‘discovered’

In a breakthrough which could help damaged livers repair naturally and quickly, scientists claim to have discovered a protein that could double the speed of liver cell growth, helping the organ to heal on its own.

A team at the Western Australian Institute for Medical Research has found that a protein, TWEAK, significantly raises the growth rate of liver progenitor cells (LPCs) – crucial stem cells in liver repair, the ‘Hepatology’ journal reported.

Lead author Dr Janina Tirnitz-Parker said when the team set out to understand how TWEAK affected LPCs, they discovered it had a dramatic effect on cell growth.

“We had LPCs growing in culture and we put TWEAK on top of them to find out what effect it might have, and what we saw was very exciting – LPCs grew twice as fast as they normally would.

“This means that there could be a potential to use TWEAK to help damaged livers repair themselves by growing new healthy cells at a much faster pace,” she said.

Head of WAIMR’s Laboratory for Liver Disease and Carcinogenesis and study co-author Professor George Yeoh said this was a significant discovery in the field and to the evolution of treatments away from liver transplants.

“This is a key finding for liver disease, because we now know what tickles liver cell growth – it could have huge benefit for patients with liver conditions by helping to regenerate their existing liver faster and possibly ruling out the need for transplants.

“If this phenomenon can be harnessed it might be possible to increase or inject TWEAK onto a patient’s liver in order to help the organ repair itself naturally, and much faster,” he said.

Oz scientists in TB drug breakthrough

Washington, March 24 (ANI): Scientists in Australia have said that they have made a new discovery that could lead to the first novel drug for Tuberculosis (TB) in almost fifty years.

Dr Nick West, Associate Faculty of the Mycobacterial group at Sydney”s Centenary Institute, is looking at the genetics of TB in the hope they will reveal a way to reduce the impact of one of the deadliest diseases in the world.

“When someone is infected with TB they either become sick immediately or the disease stays inactive, latent,” West said.

“Unfortunately, the antibiotics we use to fight TB aren”t effective against latent TB and can only be used when the disease becomes active. This is a major problem as 1 out of 10 people who have latent TB will develop the active disease, becoming sick and contagious,” West added.

West and his team have made a vital discovery in the development of a new drug that could cure TB in the latent stage. If the project succeeds, it will be the first new treatment for TB since 1962.

“We have investigated a protein that is essential for TB to survive and we have had some success in developing a drug that will inhibit this protein. Our goal over the coming months is to find out the full extent of this drug”s potential,” West said.

“If we can figure out a way to treat TB when it”s in a latent stage, then we could save millions of lives throughout the world,” West added. (ANI)

Secrets behind sharp memory in ‘super-aged’ individuals revealed

Washington, Mar 24 (ANI): The secret behind the super-sharp memory in elderly people—the so-called “super-aged” individuals—has now been unveiled.

Dr. Changiz Geula, and colleagues said that the “super-aged” individuals, actually somehow escaped formation of brain “tangles”, which consist of an abnormal form of a protein called “tau” that damages and eventually kills nerve cells.

Named for their snarled, knotted appearance under a microscope, tangles increase with advancing age and peak in people with Alzheimer”s disease.

“This discovery is very exciting. It is the first study of its kind and its implications are vast. We always assumed that the accumulation of tangles is a progressive phenomenon throughout the normal aging process. Healthy people develop moderate numbers of tangles, with the most severe cases linked to Alzheimer”s disease. But now we have evidence that some individuals are immune to tangle formation. The evidence also supports the notion that the presence of tangles may influence cognitive performance. Individuals with the fewest tangles perform at superior levels. Those with more appear to be normal for their age,” said Geula.

The findings are based on examination of the nine brains from super-aged individuals.

Subjects who volunteer for this study get a battery of memory and other tests and agree to donate their brains for examination after death. They are considered ”super- aged” because of their high performance on the tests.

The tests include memory exercises to evaluate their ability to recall facts after being told a story or their ability to remember a list of more than a dozen words and recall those words sometime later.

Geula said the new study is unique in its focus on what”s right with the brains of older people.

It looks for insights into what lifestyle, genetic, or other factors may protect super-aged individuals from the age-related memory loss that affects most other people.

The scientists found that super-aged people appear to fall into two subgroups— Those who are almost immune to tangle formation and those that have few tangles.

“One group of super-aged seems to dodge tangle formation. Their brains are virtually clean, which doesn”t happen in normal-aged individuals. The other group seems to get tangles but it”s less than or equal to the amount in the normal elderly. But for some reason, they seem to be protected against its effects,” explained Geula.

He said that the next step involves determining why one subgroup is immune to tangle formation and the other seems to be immune to its effects. Environment, lifestyle, and genetics may be key factors.

“Ultimately, chemistry is one of the keys to understanding what makes these tangles form. By understanding the specific anatomic, pathological, genetic, and molecular characteristics of high-performing brains, we may eventually be able to protect normal brains from age-related memory loss,” said Geula.

The study was presented at the 239th National Meeting of the American Chemical Society (ACS). (ANI)

Potential therapeutic target for breast cancer identified

London, March 15 (ANI): Scientists have identified a potential target for the treatment of breast cancer.

They have discovered a protein, which could stop cancer tumours from growing and spreading.

Professor Reuven Agami, of the Netherlands Cancer Institute in Amsterdam, found that the protein, known as BRD7, activates an anti-cancer gene, P53, which is already known to combat breast and other tumours.

Without the protein, the gene cannot function to stop tumours spreading.

The tumour suppressor P53 gene, present in all of us, is implicated in up to half of all tumours.

Agami found that the protein BRD7 activates P53 and could therefore suppress the development of cancer.

His said that although it is not clear how BRD7 can prevent the formation of a tumour, it is known that it is not always present in breast cancer.

Agami found that BRD7 activates P53, but when it is not present healthy cells can develop into a tumour.

“This research is very interesting because it identifies for the first time that this protein could have a role to play in a significant proportion of breast and other cancers,” the Daily Express quoted Dr Caitlin Palframan, policy manager at Breakthrough Breast Cancer, as saying.

“Further studies are now needed to confirm this protein’s role in cancer before it could be considered a potential target for new treatments,” she added.

The study has been published online in Nature Cell Biology. (ANI)

HIV uses several routes to escape immune system pressure

Washington, September 19 (ANI): Researchers at the Emory Vaccine Center have shown that HIV relies upon a number of strategies rather than use any preferred escape route to escape immune system pressure.

The human immune system has the ability to temporarily overpower HIV in early infection.

Studies conducted in the recent past have shown that most newly infected patients develop neutralizing antibodies. These are blood proteins that glob onto the virus and would allow patients to defend themselves – if they were facing only one target.

However, the problem occurs when HIV mutates, and disguises itself enough to get away from the antibodies. The virus eventually wears down the immune system into exhaustion.

The Emory team’s findings attain significance as they suggest that even if any scientist succeeds in identifying a vaccine component that can stimulate neutralizing antibodies, HIV’s capacity for rapid mutation could still be a confounding factor.

Dr. Cynthia Derdeyn, associate professor of pathology at Emory University School of Medicine, Emory Vaccine Center and Yerkes National Primate Research Center, says that a single type of neutralizing antibody may not be enough to contain HIV.

“These neutralizing antibodies work really well – they hit the virus fast and hard. But so far, every time we look, the virus escapes,” she says.

During the study, the researchers took blood samples from the participants a few weeks after infection occurred, and then later as two participants’ immune responses continued.

They isolated individual viruses over the first two years of HIV infection, and tested how well the patients’ own antibodies could neutralize them.

“In one patient where we had very early samples, there was evidence that neutralizing antibody came up within weeks, and that’s earlier than what was previously thought,” Derdeyn says.

In both patients, some viruses mutated part of their outer proteins so that after the mutation, an enzyme would be likely to attach a sugar molecule to it.

Though the sugar molecule interferes with antibody attack, this tactic, known as the “glycan shield”, was not observed in all cases.

Other viruses mutated the part of the outer protein that the neutralizing antibodies stick to directly. In both patients, many changes in the virus’ genetic code were necessary for escape.

“We need to understand early events in the immune response if we are going to figure out what a potential vaccine should have in it. What we can show is that even in one patient, several escape strategies are going on,” Derdeyn says.

According to her, that means that in order to be immune to HIV infection, someone may need to have several types of neutralizing antibodies ready to go.

Seeing how the virus mutates will allow researchers to choose the best parts to put in a vaccine, she says.

The results are online and scheduled for publication in the September issue of the journal Public Library of Science Pathogens.(ANI)

Scientists unveil antioxidant that controls spinal cord development

Washington, September 19 (ANI): John Hopkins scientists have gained significant insights into a mechanism whereby an antioxidant protein controls the activity of another protein, critical for the development of spinal cord neurons.

Writing about their work in the journal Cell, the researchers have said that it describes a never-before known mechanism of protein control.

“This is the first time we’ve seen this type of chemical reaction control neuronal differentiation. And it’s probably not specific for motor neurons that we study, but also for development of a wide variety of neurons,” says Dr. Shanthini Sockanathan, an associate professor at the Johns Hopkins Solomon H. Snyder Department of Neuroscience.

Studies conducted in the past have already shown that the GDE2 protein can cause immature cells in the spinal cord to differentiate into motor neurons, the nerve cells that connect to and control muscle contraction.

Too little GDE2 causes motor neurons to not develop, while too much GDE2 causes them to develop too quickly, depleting progenitor pools.

“We reasoned that there must be tight control of GDE2 so we set out to look for the regulator by looking for other proteins that can bind to GDE2,” says Sockanathan.

In the current study, the researchers used biochemical approaches to isolate all proteins that normally bind to GDE2 in the developing spinal cord, and then conducted proteomic analysis to identify all binding proteins.

Their effort led to the identification of a few hundred proteins.

One protein, known as Prdx1, had been reported by others to have tumour-suppressing abilities, which caught Sockanathan’s eye for further investigation.

The researchers first asked whether the Prdx1 protein could affect motor neuron development by removing it from developing spinal cords of chick embryos.

They observed that embryos lacking Prdx1 showed loss of motor neurons similar to that seen in embryos lacking GDE2, suggesting that indeed Prdx1 is somehow involved in motor neuron development.

In a bid to determine how Prdx1 and GDE2 interact to cause immature cells to develop into motor neurons, the researchers induced mutations in the proteins, and then examined how they would affect the cells.

They found that mutations that prevent the two proteins from binding resulted in no motor neurons.

Mutations that disrupt the enzyme abilities of GDE2 and Prdx1 also resulted in no motor neurons, said the researchers.

In fact, only when GDE2 and Prdx1 can bind each other and work as enzymes do motor -neurons develop.

“So we thought maybe the antioxidant enzyme activity of Prdx1 is doing something to regulate GDE2 function,” says Sockanathan.

Her team also observed that bacteria and yeast versions of Prdx1 are able to help alter certain chemical bonds in proteins that form between specific amino acids that contain so-called sulfhydryl (-SH) groups, something that led them to re-examine the GDE2 protein for these groups.

As it turns out, they found 4 in GDE2: Three are close together and one is clear on the other end of the protein.

They first performed some biochemistry experiments to determine whether these sulfhydryl groups can form disulfide bonds-they can. Then, two at a time, the researchers engineered mutations to replace each -SH-containing amino acid in GDE2, and asked whether the mutated protein could still bind to Prx1.

They found one combination of mutations that did not behave the same as the unmutated control, leading them to conclude that Prx1 must break the chemical bond between those two specific amino acids.

“We think that Prx1 breaks this bond in GDE2, activating it to promote motor neuron differentiation. This suggests a new general control mechanism that regulates when cells divide and when they differentiate. We’re excited to see how widespread it might be,” says Sockanathan. (ANI)

Weight loss can prevent kidney disease progression in obese patients

Washington, Sept 18 (ANI): Shedding extra pounds can preserve kidney function in obese people with kidney disease, according to a new study led by Indian origin scientist from Cleveland Clinic.

Weight loss can improve a number of health problems, like it can improve control of diabetes, lower blood pressure and cholesterol levels, and reduce the effects of heart disease.

During the study, Dr Sankar Navaneethan, and his colleagues analysed the studies that examined the effects of weight loss interventions in obese kidney disease patients.

It showed that weight loss attained through diet and exercise reduces proteinuria (excess excretion of protein in the urine-a hallmark of kidney damage) and may prevent additional decline in kidney function in obese patients with kidney disease.

Studies also showed that surgical interventions normalize the filtration rate of the kidneys in obese patients with high filtration rates (a risk factor for the development of kidney disease).

While the findings imply that weight reduction may prevent the progression of kidney disease in obese kidney disease patients, the authors noted that there were only a small number of studies available for analysis and additional high-quality long-term studies on this topic are needed.

The study appears in Clinical Journal of the American Society Nephrology. (ANI)

Gene linked to male infertility identified

Washington, Sept 16 (ANI): Scientists from Virginia Commonwealth University have identified a gene that may contribute to male infertility.

The research team hopes that the new findings would lead to new approaches to male contraception.

Sperm are produced in the testicles through a three-step process called spermatogenesis.

During the final stage, known as spermiogenesis, a lot of changes take place, including the packaging of DNA into the sperm head and the formation of the sperm tail, which propels the sperm cell toward the egg.

The study conducted using mouse model showed that mice lacking a protein called meiosis expressed gene 1, or MEIG1, were sterile as a result of impaired spermiogenesis – the process that encompasses changes in the sperm head and the formation of the tail.

The team also found that MEIG1 associates with the Parkin co-regulated gene protein, or PACRG protein, and that testicular PACRG protein is reduced in MEIG1-deficient mice.

PACRG is thought to play a key role in assembly of the sperm tail, and the reproductive phenotype of PACRG -deficient mice mirrors that of the MEIG1-mutant mice.

“We discovered that MEIG1 is essential for male fertility. Moreover, our findings reveal a critical role for the MEIG1/PACRG partnership in the function of a structure that is unique to sperm, the manchette. The absence of a normal manchette in mice lacking MEIG1 totally disrupts the maturation process of sperm,” said Dr Jerome F. Strauss III, dean in the VCU School of Medicine.

“In addition to having an impact on fertility, the discovery identifies a new target for drug discovery for a much needed reversible male method of contraception,” he added.

The study is published in the Early Edition of the Proceedings of the National Academy of Sciences. (ANI)

Fish sales shoot up during Ramadan in Kashmir

Srinagar, Sept 16 (ANI): Sale of trout fish in Kashmir has been witnessing an upward trend, as Muslims prefer nutritious alterative to meat varieties during the holy month of Ramadan.

Normally people eat trout fish during whole year at different occasions. But in the month of Ramadan demand for trout fish automatically increases because of its health benefits.

Long queues of customers were seen outside the sales counter in Srinagar to take home their share.

“During Ramzan, people like to eat good food. Before Ramzan, the shop is open once a week but during Ramzan it opens twice a week. It has become preferred food,” said Kaiser Ahmad, a customer.

“I think trout fish is the best food available of all the food options available to us and that is why so many are buying it. There are no scales also. It has protein and vitamins,” said Mohammed Ashraf, another customer.

The state fisheries department is providing two kilograms per head at the rate of 150 rupees per kg.

“We have to order fish again later in the day as stock lasts only few hours. We try to supply fresh fish to our customers,” said Mohammed Hussain Wani, fisheries marketing officer.

Trout is a delicious and a very energetic food. It has a number of vitamins and doctors also advise people to use trout fish in large quantities in place of meat. By Afzal Butt(ANI)

Master gene that switches on disease-fighting cells identified

London, Sep 14 (ANI): British scientists have identified the master gene, called E4bp4, that causes blood stem cells to turn into disease-fighting ‘Natural Killer’ (NK) immune cells.

The discovery, by researchers at Imperial College London, UCL and the Medical Research Council’s National Institute for Medical Research, could one day help scientists boost the body’s production of these frontline tumour-killing cells, creating new ways to treat cancer.

By ‘knocking out’ E4bp4 in a mouse model, the researchers created the world’s first animal model entirely lacking NK cells, but with all other blood cells and immune cells intact.

The breakthrough model should help solve the mystery of the role that Natural Killer cells play in autoimmune diseases, such as diabetes and multiple sclerosis.

According to many scientists, these diseases are a result of malfunctioning NK cells that turn on the body and attack healthy cells, which cause disease instead of fighting it.

They believe that clarifying NK cells’ role could lead to new ways of treating these conditions.

Natural Killer cells – a type of white blood cell – are a major component of the human body’s innate, quick-response immune system, providing a fast frontline defence against tumours, viruses and bacterial infections.

The gene E4bp4 is the ‘master gene’ for NK cell production, which means it is the primary driver that causes blood stem cells in the bone marrow to differentiate into NK cells.

Led by Dr Hugh Brady, the researchers are hoping to progress with a drug treatment for cancer patients which reacts with the protein expressed by their E4bp4 gene, causing their bodies to produce a higher number of NK cells than normal, to increase the chances of successfully destroying tumours.

“If increased numbers of the patient’s own blood stem cells could be coerced into differentiating into NK cells, via drug treatment, we would be able to bolster the body’s cancer-fighting force, without having to deal with the problems of donor incompatibility,” Nature quoted Brady as saying.

The researchers proved the pivotal role E4bp4 plays in NK production when they knocked the gene out in a mouse model.

Without E4bp4 the mouse produced no NK cells whatsoever but other types of blood cell were unaffected.

“Now finally, with our discovery of the NK cell master gene and subsequent creation of our mouse model, we will be able to find out if the progression of these diseases is impeded or aided by the removal of NK cells from the equation. This will solve the often-debated question of whether NK cells are always the ‘good guys’, or if in certain circumstances they cause more harm than good,” said Brady.

The study has been published in Nature Immunology. (ANI)

How people lose muscles as they get older

Washington, Sep 12 (ANI): Even the most well-built people tend to loose their muscles and develop thinner arms and legs as they get older, and researchers in Nottingham have now explained why this happens.

As age catches up, it becomes harder to keep our muscles healthy-they get smaller, which decreases strength and increases the likelihood of falls and fractures.

The researchers have already shown that when older people eat, they cannot make muscle as fast as the young, and now they have found that the suppression of muscle breakdown, which also happens during feeding, is blunted with age.

Led by Michael Rennie, the scientists and doctors at The University of Nottingham Schools of Graduate Entry Medicine and Biomedical Sciences, believe that a ‘double whammy’ affects people aged over 65.

But the team think that weight training may “rejuvenate” muscle blood flow, and help retain muscle for older people.

The study’s results may explain the ongoing loss of muscle in older people- when they eat they do not build enough muscle with the protein in food and also, the insulin (a hormone released during a meal) fails to shut down the muscle breakdown that rises between meals and overnight.

Normally, in young people, insulin acts to slow muscle breakdown.

These problems could be a result of a failure to deliver nutrients and hormones to muscle because of a poorer blood supply.

In the study, the researchers compared one group of people in their late 60s to a group of 25-year-olds, with equal numbers of men and women.

Professor Rennie said: “The results were clear. The younger people’s muscles were able to use insulin we gave to stop the muscle breakdown, which had increased during the night. The muscles in the older people could not.”

“In the course of our tests, we also noticed that the blood flow in the leg was greater in the younger people than the older ones. This set us thinking: maybe the rate of supply of nutrients and hormones is lower in the older people? This could explain the wasting we see,” he added.

Later, Beth Phillips, a PhD student working with Rennie, confirmed the blunting effect of age on leg blood flow after feeding, with and without exercise.

The team predicted that weight training would reduce this blunting.

“Indeed, she found that three sessions a week over 20 weeks ‘rejuvenated’ the leg blood flow responses of the older people. They became identical to those in the young,” said Rennie.

The study has been published in The American Journal of Clinical Nutrition. (ANI)

New method to monitor early sign of oxidative stress that triggers cancer

Washington, Sept 12 (ANI): Scientists from University of Michigan have developed a new method to monitor early sign of oxidative stress that triggers cancer spread.

Lead researcher Kate Carroll suggests that being able to monitor a marker of oxidative stress that is associated with the activation of tumor cell growth pathways, particularly at an early stage, and then tailor treatments accordingly would allow for more targeted studies and might improve the odds of success with antioxidants and pro-oxidants.

The new method detects sulfenic acid in proteins-a tip off to early oxidative stress and to a specific protein modification associated with cell growth pathways.

Sulfenic acid is produced when a particular oxidant, hydrogen peroxide, reacts with the protein building block cysteine. But because the chemical modification involved is so small and transient, it has been difficult to detect.

To get around that problem, Carroll and Seo used a chemical probe that “traps” sulfenic acid and tags it for recognition by an antibody.

The antibody is labeled with a fluorescent dye that glows when observed with a fluorescence microscope.

The researchers then used the method to assess sulfenic acid levels as a marker of oxidative stress in several systems, including a panel of breast cancer cell lines.

“For each line, we saw a very distinct pattern of sulfenic acid modifications,” indicating different oxidative stress levels and hinting at differences in the underlying molecular events associated with tumor growth,” said Carroll, assistant professor of chemistry and a research assistant professor in the Life Sciences Institute.

“Whether the patterns we see will correlate with response to antioxidant treatment or other therapies that modulate oxidative stress level remains to be seen, but now we at least have a way to investigate that question,” the expert added.

The study appears in Proceedings of the National Academy of Sciences. (ANI)

Exposure to second-hand tobacco smoke linked to liver disease

Washington, September 11 (ANI): People can develop liver disease even when they are exposed to second-hand tobacco smoke, according to a study.

Scientists at the University of California, Riverside (UCR) have found that exposure to second-hand tobacco smoke can lead to non-alcoholic fatty liver disease (NAFLD), a common disease and rising cause of chronic liver injury wherein fat accumulates in the liver of people who drink little or no alcohol.

For their study, the researchers exposed some mice to second-hand cigarette smoke for a year in the lab, and observed fat build-up in their liver cells, a sign of NAFLD that eventually leads to liver dysfunction.

The researchers focused on two key regulators of lipid (fat) metabolism that are found in many human cells as well: SREBP (sterol regulatory element-binding protein) that stimulates synthesis of fatty acids in the liver, and AMPK (adenosine monophosphate kinase) that turns SREBP on and off.

They found that second-hand smoke exposure inhibits AMPK activity, which, in turn, causes an increase in activity of SREBP.

More active SREBP results in more fatty acids getting synthesized, they say.

The result is NAFLD induced by second-hand smoke, according to the researchers.

“Our study provides compelling experimental evidence in support of tobacco smoke exposure playing a major role in NAFLD development,” said Manuela Martins-Green, a professor of cell biology, who led the study.

“Our work points to SREBP and AMPK as new molecular targets for drug therapy that can reverse NAFLD development resulting from second-hand smoke. Drugs could now be developed that stimulate AMPK activity, and thereby inhibit SREBP, leading to reduced fatty acid production in the liver,” Martins-Green added.

A research article describing the study has been published in the Journal of Hepatology. (ANI)